a 802715 has been researched along with gentian violet in 1 studies
| Studies (a 802715) | Trials (a 802715) | Recent Studies (post-2010) (a 802715) | Studies (gentian violet) | Trials (gentian violet) | Recent Studies (post-2010) (gentian violet) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 2,796 | 51 | 1,008 |
| Protein | Taxonomy | a 802715 (IC50) | gentian violet (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.473 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.148 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 1.43 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.005 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 3.6337 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.535 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.536 | |
| Adenosine receptor A3 | Homo sapiens (human) | 4.166 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.8244 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.8 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.095 | |
| D(2) dopamine receptor | Homo sapiens (human) | 3.178 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 5.57 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 4.166 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.258 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.884 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 4.33 | |
| Substance-K receptor | Homo sapiens (human) | 1.679 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 3.102 | |
| Acetylcholinesterase | Homo sapiens (human) | 5.847 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.155 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.98 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 2.627 | |
| Adenosine receptor A2a | Homo sapiens (human) | 3.365 | |
| Mu-type opioid receptor | Homo sapiens (human) | 2.145 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.831 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 1.54 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 4.166 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.8 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 4.069 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binder, A; Bohm, L; Theron, T | 1 |
1 other study(ies) available for a 802715 and gentian violet
| Article | Year |
|---|---|
Influence of pentoxifylline, A-802710, propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage.
Topics: Caffeine; Cell Cycle; Dose-Response Relationship, Drug; Enzyme Inhibitors; G2 Phase; Gentian Violet; Growth Inhibitors; Humans; Indicators and Reagents; Mitosis; Molecular Structure; Nocodazole; Pentoxifylline; Radiation-Sensitizing Agents; S Phase; Time Factors; Tumor Cells, Cultured; Xanthines | 2000 |